XML 29 R89.htm IDEA: XBRL DOCUMENT v2.4.1.9
Unaudited Interim Financial Information - Additional Information (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Quarterly Financial Data [Line Items]                      
Income Tax benefit as a result of completion of IRS examinations for tax years 2008 through 2010       $ (10.9)us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions   $ (2.2)us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions     $ (10.9)us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions    
Gain on sale of an equity investment       7.1us-gaap_GainLossOnSaleOfEquityInvestments              
Acquisition-related items 7.5bcr_BusinessCombinationAcquisitionRelatedItems   22.5bcr_BusinessCombinationAcquisitionRelatedItems 3.1bcr_BusinessCombinationAcquisitionRelatedItems 14.0bcr_BusinessCombinationAcquisitionRelatedItems 33.7bcr_BusinessCombinationAcquisitionRelatedItems          
Increase (decrease) in net income (loss) attributable to common share holders (24.7)bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders (18.3)bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders (262.4)bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders 13.5bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders 552.8bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders (29.1)bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders (277.1)bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders (29.3)bcr_IncreaseDecreaseInNetIncomeAttributableToCommonShareholders      
Increase (decrease) in diluted earnings per share available to common shareholders $ (0.32)bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ (0.24)bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ (3.37)bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ 0.17bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ 6.86bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ (0.36)bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ (3.35)bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders $ (0.35)bcr_IncreaseDecreaseInDilutedEarningsPerShareAvailableToCommonShareholders      
Litigation charges, net     262.7bcr_LitigationCharges   109.8bcr_LitigationCharges   292.4bcr_LitigationCharges 25.8bcr_LitigationCharges      
Acquisition related item, purchased accounting adjustment 5.0bcr_PurchaseAccountingAdjustment   20.7bcr_PurchaseAccountingAdjustment                
Litigation related defense costs 12.7us-gaap_LitigationSettlementExpense 13.2us-gaap_LitigationSettlementExpense             30.1us-gaap_LitigationSettlementExpense    
Asset impairments   6.2us-gaap_AssetImpairmentCharges       3.4us-gaap_AssetImpairmentCharges 3.2us-gaap_AssetImpairmentCharges 5.7us-gaap_AssetImpairmentCharges 6.8us-gaap_AssetImpairmentCharges 12.3us-gaap_AssetImpairmentCharges 22.2us-gaap_AssetImpairmentCharges
Restructuring and productivity initiative costs 10.1bcr_RestructuringAndOtherRelatedCosts               11.8bcr_RestructuringAndOtherRelatedCosts (2.1)bcr_RestructuringAndOtherRelatedCosts 17.4bcr_RestructuringAndOtherRelatedCosts
Reversal of excise tax paid 3.5bcr_ReversalOfMedicalDeviceExciseTax                    
Reversal of restructuring costs             1.4us-gaap_RestructuringReserveAccrualAdjustment        
Acquisition related item, purchased IPR&D charge           29.5us-gaap_ResearchAndDevelopmentInProcess     2.6us-gaap_ResearchAndDevelopmentInProcess 30.0us-gaap_ResearchAndDevelopmentInProcess 3.5us-gaap_ResearchAndDevelopmentInProcess
Divestiture-related charges         7.8bcr_BusinessDivestitureCostTransactionCosts 9.7bcr_BusinessDivestitureCostTransactionCosts     0bcr_BusinessDivestitureCostTransactionCosts 17.5bcr_BusinessDivestitureCostTransactionCosts 0bcr_BusinessDivestitureCostTransactionCosts
Acquisition costs, integration costs         11.2us-gaap_BusinessCombinationIntegrationRelatedCosts       2.3us-gaap_BusinessCombinationIntegrationRelatedCosts 11.3us-gaap_BusinessCombinationIntegrationRelatedCosts 2.1us-gaap_BusinessCombinationIntegrationRelatedCosts
Other income (expense), net, Gore Proceeds         894.3us-gaap_LitigationSettlementAmount       0us-gaap_LitigationSettlementAmount 894.3us-gaap_LitigationSettlementAmount 0us-gaap_LitigationSettlementAmount
Gain on the sale of BEP         213.0us-gaap_GainLossOnSaleOfBusiness       0us-gaap_GainLossOnSaleOfBusiness 213.0us-gaap_GainLossOnSaleOfBusiness 0us-gaap_GainLossOnSaleOfBusiness
Contribution to the C. R. Bard Foundation, Inc.         $ 22.5bcr_ContributionToCharitableFoundation       $ 0bcr_ContributionToCharitableFoundation $ 25.0bcr_ContributionToCharitableFoundation $ 2.5bcr_ContributionToCharitableFoundation